May/June 2000

Vol 7, No 3 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• evaluate a thyroid nodule,
• be aware of the factors relevant to assessing outcomes from thyroid cancer,
• understand the diagnosis and management of medullary thyroid carcinoma,
• be familiar with the surgical options for thyroid cancer treatment, and
• appreciate roles for high-dose chemotherapy for Hodgkin's disease.

This program was planned in accordance with ACCME Essentials.

Release Date: May 1, 2000
Expiration Date: May 1, 2001

Pretest

1. Which diagnostic method is considered the current "gold standard" for the diagnosis of thyroid nodules?

a. thyroid scintiscan

b. CT or MRI of the neck

c. fine-needle aspiration

d. ultrasound

2. The MACIS prognostic score, which was developed at the Mayo Clinic for papillary thyroid cancer and is based on metastasis, age, completeness of resection, local invasion, and tumor size, allows categorization of patients into low- and high-risk groups. What is the cause-specific mortality at 20 years for low-risk patients?

a. 1%

b. 3%

c. 9%

d. 12%

3. What is the prognosis for patients with MEN 2A syndrome or familial medullary thyroid cancer when total thyroidectomy is performed after medullary thyroid cancer is detected by RET proto-oncogene screening and before the onset of clinical disease?

a. usually cured

b. 85% 5-year survival

c. 70% 5-year survival

d. 40% 5-year survival